KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Return on Assets (2016 - 2025)

Nektar Therapeutics (NKTR) has 15 years of Return on Assets data on record, last reported at 0.45% in Q3 2025.

  • For Q3 2025, Return on Assets rose 7.0% year-over-year to 0.45%; the TTM value through Sep 2025 reached 0.45%, up 7.0%, while the annual FY2024 figure was 0.34%, 16.0% up from the prior year.
  • Return on Assets reached 0.45% in Q3 2025 per NKTR's latest filing, up from 0.5% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.29% in Q1 2021 and bottomed at 0.66% in Q1 2023.
  • Average Return on Assets over 5 years is 0.49%, with a median of 0.48% recorded in 2024.
  • Peak YoY movement for Return on Assets: fell -22bps in 2022, then increased 27bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.44% in 2021, then decreased by -15bps to 0.5% in 2022, then crashed by -30bps to 0.65% in 2023, then surged by 41bps to 0.39% in 2024, then fell by -15bps to 0.45% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.45% in Q3 2025, 0.5% in Q2 2025, and 0.46% in Q1 2025.